|
US9340577B2
(en)
|
1992-08-07 |
2016-05-17 |
Epimmune Inc. |
HLA binding motifs and peptides and their uses
|
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
CA2323632A1
(en)
*
|
1998-03-13 |
1999-09-16 |
Epimmune Inc. |
Hla-binding peptides and their uses
|
|
WO2000044775A2
(en)
*
|
1999-01-27 |
2000-08-03 |
Epimmune Inc. |
Identification of broadly reactive hla restricted t cell epitopes
|
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
|
EP1230268B1
(en)
*
|
1999-11-18 |
2009-10-14 |
Pharmexa Inc. |
Heteroclitic analogs of class i epitopes
|
|
US7462354B2
(en)
|
1999-12-28 |
2008-12-09 |
Pharmexa Inc. |
Method and system for optimizing minigenes and peptides encoded thereby
|
|
DK1299727T3
(da)
|
2000-07-12 |
2009-06-15 |
Agensys Inc |
Hidtil ukendt tumorantigen, der er egnet til diagnosticering og behandling af blære-, ovarie-, lunge-, og nyrecancertyper
|
|
CA2705366A1
(en)
|
2000-08-28 |
2002-03-07 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
|
|
WO2002060953A2
(en)
*
|
2000-12-15 |
2002-08-08 |
Agensys, Inc. |
Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
|
|
US6924358B2
(en)
|
2001-03-05 |
2005-08-02 |
Agensys, Inc. |
121P1F1: a tissue specific protein highly expressed in various cancers
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
IL158860A0
(en)
*
|
2001-05-15 |
2004-05-12 |
Agensys Inc |
Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same
|
|
US7842480B2
(en)
|
2001-05-18 |
2010-11-30 |
Mayo Foundation For Medical Education And Research |
Chimeric antigen-specific t cell-activating polypeptides
|
|
US20060222656A1
(en)
|
2005-04-01 |
2006-10-05 |
University Of Maryland, Baltimore |
MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
|
|
EP2287186B1
(en)
|
2001-09-06 |
2014-12-31 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
|
|
EP1495322A4
(en)
*
|
2002-04-05 |
2006-09-06 |
Epimmune Inc |
HETEROKLITIC ANALOGUES AND ASSOCIATED METHODS
|
|
JP2005535627A
(ja)
*
|
2002-06-25 |
2005-11-24 |
シティ・オブ・ホープ |
アジュバント不含ペプチド・ワクチン
|
|
AU2003243151A1
(en)
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
|
EP1565200A4
(en)
|
2002-11-27 |
2009-06-24 |
Agensys Inc |
NUCLEIC ACID 24P4C12 AND CORRESPONDING PROTEIN FOR THE TREATMENT AND DETECTION OF CANCER
|
|
JP2007524361A
(ja)
|
2003-02-10 |
2007-08-30 |
アジェンシス， インコーポレイテッド |
膀胱癌及びその他の癌の治療及び検出に有用な名称１５８ｐ１ｄ７の核酸及び対応タンパク質
|
|
CA2526274C
(en)
|
2003-05-30 |
2015-12-01 |
Agensys, Inc. |
Prostate stem cell antigen (psca) variants and subsequences thereof
|
|
NZ551627A
(en)
|
2004-05-28 |
2010-02-26 |
Agensys Inc |
Antibodies and related molecules that bind to PSCA proteins
|
|
RU2413735C2
(ru)
|
2005-03-31 |
2011-03-10 |
Эдженсис, Инк. |
Антитела и родственные молекулы, связывающиеся с белками 161p2f10b
|
|
CN101370517B
(zh)
*
|
2006-01-23 |
2012-12-05 |
株式会社绿多肽 |
来源于c型肝炎病毒的肽
|
|
EP1982992B1
(en)
|
2006-02-07 |
2010-10-27 |
NEC Corporation |
Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
|
|
EP2085474A4
(en)
|
2006-10-12 |
2010-12-01 |
Nec Corp |
HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
|
|
JP2011502484A
(ja)
|
2007-11-01 |
2011-01-27 |
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ |
Ｈｌａ−ｄｒ結合性ペプチドおよびそれらの使用
|
|
EP2391635B1
(en)
*
|
2009-01-28 |
2017-04-26 |
Epimmune Inc. |
Pan-dr binding polypeptides and uses thereof
|
|
AU2012258603A1
(en)
|
2011-05-26 |
2014-01-16 |
Geneius Biotechnology, Inc. |
Modulated immunodominance therapy
|
|
CN110651189B
(zh)
|
2017-03-03 |
2024-10-25 |
特雷斯生物有限公司 |
肽疫苗
|
|
JP7642530B2
(ja)
|
2018-09-04 |
2025-03-10 |
トレオス バイオ リミテッド |
ペプチドワクチン
|
|
US11421015B2
(en)
|
2020-12-07 |
2022-08-23 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
US11058751B1
(en)
|
2020-11-20 |
2021-07-13 |
Think Therapeutics, Inc. |
Compositions for optimized RAS peptide vaccines
|
|
CN116710115A
(zh)
|
2020-11-20 |
2023-09-05 |
思维疗法股份有限公司 |
用于优化的肽疫苗的组合物和方法
|
|
US11161892B1
(en)
|
2020-12-07 |
2021-11-02 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
US11464842B1
(en)
|
2021-04-28 |
2022-10-11 |
Think Therapeutics, Inc. |
Compositions and method for optimized peptide vaccines using residue optimization
|